CRIS Current Research Information System

LENZI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.307
AS - Asia 6.092
EU - Europa 4.677
AF - Africa 375
SA - Sud America 303
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.229
VN - Vietnam 1.904
SG - Singapore 1.528
CN - Cina 1.499
GB - Regno Unito 1.135
IT - Italia 893
DE - Germania 584
SE - Svezia 572
HK - Hong Kong 345
FR - Francia 308
IN - India 286
UA - Ucraina 259
RU - Federazione Russa 239
BR - Brasile 203
IE - Irlanda 153
NL - Olanda 117
JP - Giappone 111
KR - Corea 95
ZA - Sudafrica 92
FI - Finlandia 91
EE - Estonia 86
CI - Costa d'Avorio 80
TG - Togo 67
AR - Argentina 56
CH - Svizzera 54
SC - Seychelles 51
CA - Canada 48
PH - Filippine 44
BG - Bulgaria 33
BD - Bangladesh 32
TR - Turchia 31
JO - Giordania 30
TH - Thailandia 29
AT - Austria 27
ID - Indonesia 27
NG - Nigeria 26
PL - Polonia 24
PK - Pakistan 22
IQ - Iraq 21
MX - Messico 20
BE - Belgio 19
TW - Taiwan 17
AU - Australia 16
ES - Italia 16
IR - Iran 13
EC - Ecuador 12
HR - Croazia 12
MA - Marocco 12
GR - Grecia 11
RO - Romania 10
SA - Arabia Saudita 10
TN - Tunisia 10
EG - Egitto 9
MY - Malesia 9
VE - Venezuela 9
LT - Lituania 8
UZ - Uzbekistan 8
DZ - Algeria 7
KE - Kenya 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
CL - Cile 5
CZ - Repubblica Ceca 5
AO - Angola 4
NP - Nepal 4
OM - Oman 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CO - Colombia 3
LB - Libano 3
LV - Lettonia 3
MM - Myanmar 3
NO - Norvegia 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
CG - Congo 2
DK - Danimarca 2
GH - Ghana 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
PE - Perù 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
Totale 18.766
Salva come PNG Salva come JPEG
Città #
Singapore 1.049
Southend 977
Fairfield 745
Ashburn 733
Chandler 585
Dong Ket 451
San Jose 383
Houston 363
Woodbridge 360
Wilmington 342
Seattle 339
Ho Chi Minh City 331
Hong Kong 319
Hanoi 304
Santa Clara 291
Cambridge 266
Ann Arbor 263
Hefei 222
Princeton 213
Beijing 171
Jacksonville 163
Dublin 152
Bologna 145
Boardman 144
Lauterbourg 114
Nanjing 104
Padova 97
Westminster 95
Tokyo 90
Los Angeles 85
Helsinki 81
Abidjan 80
Seoul 76
Berlin 75
Jinan 73
Milan 72
Lomé 67
Dallas 66
Da Nang 61
Buffalo 60
Frankfurt am Main 59
New York 58
Haiphong 56
Shenyang 56
Saint Petersburg 41
Bern 39
San Diego 38
Changsha 37
Council Bluffs 37
Rome 36
Bremen 33
Mülheim 32
Sofia 32
Guangzhou 31
Amman 30
Redondo Beach 30
Des Moines 29
Hebei 29
Tianjin 29
Turin 29
Nanchang 28
São Paulo 28
Abeokuta 26
Phoenix 26
London 24
Bengaluru 22
Chicago 22
Biên Hòa 21
Florence 21
Medford 21
Zhengzhou 21
Falls Church 20
Hải Dương 19
Jiaxing 19
Munich 19
Shanghai 19
Brussels 18
Can Tho 18
Haikou 18
Hangzhou 18
Falkenstein 17
Orem 17
Verona 17
Vienna 17
Yubileyny 17
Toronto 16
Amsterdam 15
Mahé 15
Nuremberg 15
Taiyuan 15
Modena 14
Norwalk 14
Thái Nguyên 14
Warsaw 14
Dearborn 13
Washington 13
Bühl 12
Düsseldorf 12
Montreal 12
Olalla 12
Totale 12.087
Salva come PNG Salva come JPEG
Nome #
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 365
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 307
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 295
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 277
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 271
A deterministic solution of the Boltzmann transport equation for a one-dimensional electron gas in silicon nanowires 261
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 259
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 258
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 254
Clinical and serological profile of primary biliary cirrhosis in men. 243
Antinuclear antibodies in COVID 19 239
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 237
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 234
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 234
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 229
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 226
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 226
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 216
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 216
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 212
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 208
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 206
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 203
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 202
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 200
Autoantibodies in Autoimmune Hepatitis 198
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 197
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 195
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 193
HCV liver infection and liver steatosis:evidence for indirect mechanisms in genotype 3? 191
Semiclassical transport in silicon cylindrical nanowire FETs including surface roughness 190
Diagnosis and therapy of autoimmune hepatitis. 187
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 186
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 186
Autoimmune liver disease 2007. 184
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry 183
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 183
Blood-Based Non-Invasive Tests of Hepatic Fibrosis in Autoimmune Hepatitis: Application among Selected Patients Leads to Higher Accuracy 180
Autoimmune hepatitis in Italy: the Bologna experience. 180
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 177
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 176
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study 175
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 175
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 175
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 173
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 173
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 172
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 171
Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases 171
Autoimmune hepatitis 170
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 169
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 169
Specific antinuclear reactivities in primary biliary cirrhosis 166
Standardization of Autoantibody Testing in Autoimmune Hepatitis 164
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 163
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 162
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 161
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 159
Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia. 158
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 157
Diagnostic approach to autoimmune hepatitis 155
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 151
HCV and autoimmunity. 149
Acute liver injury and anorexia nervosa: A case report 148
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. 147
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 147
Diagnosis of primary biliary cholangitis in a "teen" male patient 146
Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. 146
Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report 143
Development of autoimmune hepatitis after influenza vaccination; trigger or killer? 142
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 138
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 137
Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis 136
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD 134
EASL Clinical Practice Guidelines: Autoimmune hepatitis 134
Serum Smooth Muscle Antibodies (SMA). 133
Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing 132
Genetic distinction between autoimmune hepatitis in Italy and North America 131
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 131
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 131
Nailfold capillaroscopy in primary biliary cirrhosis: a useful tool for the early diagnosis of scleroderma. 126
Coronavirus disease associated immune thrombocytopenia: Causation or correlation? 126
Expert clinical management of autoimmune hepatitis in the real world 123
Current topics in autoimmune hepatitis. 123
Role of the HLA class II: HCV-related disorders. 122
Preliminary classification criteria for the cryoglobulinaemic vasculitis 121
LKM1-positive type 2 autoimmune hepatitis following allogenic haematopoietic stem-cell transplantation. 120
Non organ specific autoantibodies in children with chronic hepatitis C virus infection 119
Smooth muscle antibodies and type 1 autoimmune hepatitis 116
A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center 116
Susceptibility to thyroid disorders in hepatitis C 115
Vitamin D in autoimmune liver disease 114
Missed treatment in an Italian HBV infected patients cohort: HBV RER 114
Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset 114
The role of invariant NKT in autoimmune liver disease: Can Vitamin D Act as an Immunomodulator? 113
Liver HCV-antigens and steatosis in chronic hepatitis C: role of different genotypes 112
Genetic distinction between autoimmune hepatitis in Italy and North America: regional differences in the importance of HLA DR4 111
null 108
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 107
Totale 17.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.685
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021782 0 0 0 0 0 0 0 0 0 0 81 701
2021/20222.155 212 72 126 182 186 119 64 124 73 143 514 340
2022/20232.267 286 323 121 293 152 170 60 125 376 78 178 105
2023/2024650 52 87 35 56 46 103 26 53 31 26 73 62
2024/20252.572 136 398 259 212 427 145 129 76 41 167 96 486
2025/20265.628 510 510 505 408 645 313 626 194 1.274 489 154 0
Totale 19.064